Phosphoregulation for Therapeutic Interventions in Cancer? Phosphoregulatory Map of Checkpoint Kinase 1 (CHK1)...

Area of Science:

• Molecular Biology
• Cellular Signaling
• Genomics

Background:

• Checkpoint kinase 1 (CHK1) is essential for maintaining genomic stability and coordinating DNA damage response (DDR).
• CHK1 phosphorylation acts as a key regulator of checkpoint control and DNA repair pathways.
• The comprehensive phosphorylation network of CHK1 and its role in DDR remains largely unexplored, presenting therapeutic opportunities.

Purpose of the Study:

• To systematically analyze global phosphoproteomic datasets to map the CHK1 phosphorylation landscape.
• To identify coregulated protein phosphosites associated with CHK1 phosphorylation within DDR signaling networks.
• To uncover novel regulatory layers and potential therapeutic targets by visualizing CHK1 phosphosite networks.

Main Methods:

• Integrative analysis of 577 qualitative and 120 quantitative cellular phosphoproteomic datasets.
• Systematic visualization of CHK1 phosphosites and their co-occurring protein phosphosites.
• Coregulation analysis of CHK1 phosphosites with its substrates, regulators, and interacting proteins.

Main Results:

• Identified distinct signatures of the CHK1 phosphorylation landscape.
• Visualized a strong co-occurrence of DDR-associated phosphosites, particularly with CHK1-S280.
• Discovered Ataxia telangiectasia and Rad3-related protein-dependent CHK1-S317 phosphosites outside the kinase domain.
• Uncovered connectivity between CHK1 phosphosites and DDR regulators through coregulation analysis.

Conclusions:

• The phosphosite-concordance approach provides a regulatory map of CHK1 phosphorylation patterns.
• New regulatory layers and mechanistic insights into CHK1 phosphoregulation were uncovered.
• Highlights CHK1 phosphoregulation as a promising target for therapeutic interventions in cancer.